Navigation Links
Mens Sexual Prowess Not Affected by Prostate Cancer Drug

Men worried about taking finasteride, a drug proven effective in preventing prostate cancer, just because it might effect their performance in the bedroom, can now put their fears to rest, thanks to a new study.

The study, by researchers from the Southwest Oncology Group, found that though the drug does cause a drop in sexual function, the effects diminish over the course of time.

As a part of their study, the researchers surveyed more than 17,000 men 55 and older for seven years, and found that though men given finasteride reported on average more dysfunction than did men given a placebo, the small effect diminished over the seven years.

The study was led by Carol Moinpour, Ph.D., of the Fred Hutchison Cancer Research Center in Seattle.

The study grew out of the Prostate Cancer Prevention Trial, a large double-blind National Cancer Institute-funded study which found that finasteride, a drug which curbs the proliferation of prostate gland cells, is effective at preventing prostate cancer in men age 55 and older.

The 2003 results of that trial, conducted by the Southwest Oncology Group in more than 18,000 men, showed that finasteride could reduce a mans chances of getting prostate cancer by almost 25 percent.

In earlier studies, some men taking finasteride reported decreased libido, impotence and other signs of diminished sexual function. But researchers conducting the new study reported that the previous studies were studies were short-term and didnt try to assess the effects of age and other health factors, as well as individual variation.

The study authors used two surveys, a widely used Sexual Problems Scale and another questionnaire which they created, the Sexual Activity Scale. They also gathered other data to take into account other health factors that affect sexual function, such as age, medical conditions and smoking status. They surveyed the subjects three
'"/>




Page: 1 2

Related medicine news :

1. Sexual abuse affect health for a lifetime
2. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
3. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
4. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
5. Condom Vending Machines Increasing Sexual Assaults On Women
6. Sexually Abused Girls Develop Eating Disorders
7. Gynaecologist Faces Stiff Prison Sentence On Counts Of Sexual Abuse
8. New Sexual Misconduct Rule Against Doctors In The US
9. Historic Increase In Incidence Of Sexually Transmitted Diseases In Scotland
10. Youth Becoming Sexually Active At A Younger Age
11. Epilepsy Medicine May Result In Sexual Dysfunction
Post Your Comments:
(Date:12/1/2008)... emission mammography (PEM), a new technique for i...t density or a woman,s hormonal status, two factor...aphy and MRI at detecting cancer. Results will be ...logical Society of North America (RSNA). , "The ... be adversely affected by breast density, hormone ...
(Date:12/1/2008)...Call/ -- The Ensign Group, Inc.,(Nasdaq: ENSG )...ation Center in,Pocatello, Idaho has successfully...caid Services, Special Focus program. , (Lo.../LATH168LOGO ) , A clinical team led by Lau...& Rehabilitation Center, completed the complex...
(Date:12/1/2008)...ial Sloan-Kettering Cancer Center, New York, have ...n of genes for therapeutic purposes, and used this..., Small, noncoding RNA molecules known as miRNAs...n. In the study, the miRNA miR-181a was harnessed ...nown as T cells at different stages of their devel...
(Date:12/1/2008)...-- ViroPharma Incorporated,(Nasdaq: VPHM ) toda...tal,Biologics License Application (sBLA) to the U...e(TM) C1 Inhibitor (human) as a treatment for acut... The sBLA is based on a re-analysis and resubmiss...t study of Cinryze and interim data from an ongoin...
Breaking Medicine News(10 mins):Health News:New mammography technology effective in detecting breast cancer 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5
...vior in her daughter, who helped raise the life-sa... could be made available for her to fight debilita... had refused the cancer drug to Mrs. Morgan, of Wh...nd all of ten, wrote to Shropshire MP Owen Paterso...
...ng noted that fewer Americans are eating 'risky' f...icans consume each day are becoming far safer now ...n food borne illness, released at the Internationa...seases in Atlanta, led researchers to conclude tha...
...shedpur have blamed the administration for the pro... the editor of the Journal of Indian Medical Assoc...f the Indian Medical Association, Ajay Kumar Singh... of violence against doctors is because of the gov...
...ee that the woman who sued them for ?250,000 over ... eventually gave birth to her daughter Jayde and s...sked for maintenance for the girl. However, the ... then aged 16 was given no guarantees that the abo...
Other Medicine News:Health News:Americans Avoiding Risky Foods 2
(Date:11/30/2008).... 1 Abnormalities in au... children with autism spectrum disorder by using m...presented today at the annual meeting of the Radio... "Using MEG, we can record the tiny magnetic fiel...d Timothy Roberts, Ph.D., vice chair of research i...
(Date:11/26/2008)...formation density, automation and intelligent clin...asound to an all new level , , CHICAGO, Ill...althcare ( www.siemens.com/healthcare ) highligh...anner (ABVS)(1), the world,s first multi-use, aut...h Scientific Assembly and Annual Meeting of the Ra...
(Date:11/25/2008)...ANCISCO, Calif., Nov. 25 Proteolix... of novel therapeutics that target,protein degrad...today,announced that data from two ongoing Phase ...oma will be presented at the upcoming 50th Annual ...H). Carfilzomib is the first in a new class,of s...
(Date:11/24/2008)...ll., and OSAKA, Japan, Nov. 24 Tak...owned subsidiary, Takeda Global Research & Dev...the Arthritis Advisory Committee of the U.S. Food ... FDA approve febuxostat for the treatment of hype...o zero in favor of approval, with one panel member...
Breaking Medicine Technology:Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Kids Who Sleep Poorly at Risk for Being Overweight 24953 1Kids Who Sleep Poorly at Risk for Being Overweight 24953 2Video 3A Communication is Key to Ease Worry about Orthopaedic Surgery 24951 1Video 3A Communication is Key to Ease Worry about Orthopaedic Surgery 24951 2Video 3A Communication is Key to Ease Worry about Orthopaedic Surgery 24951 3MINRAD International Inc to Discuss 2008 Second Quarter Financial Results on Thursday August 14 2008 24949 1MINRAD International Inc to Discuss 2008 Second Quarter Financial Results on Thursday August 14 2008 24949 21st World Congress On Interventional Therapies for Type 2 Diabetes 24947 11st World Congress On Interventional Therapies for Type 2 Diabetes 24947 21st World Congress On Interventional Therapies for Type 2 Diabetes 24947 31st World Congress On Interventional Therapies for Type 2 Diabetes 24947 4
Nucleus manipulator facilitates lens rotation during phacoemulsification.
This double ended instrument was designed to lift and reposition a previous corneal flap up to one year postoperatively. The curved chisel end is designed to enable the surgeon to lift the edge and t
Smaller than the kuglen hook, this manipulator offers excellent grasping or lifting of the nucleus. Blunt finger-like 0.5 mm two-prong tip. Round knurled handle with dull finish. Straight.
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification.
Medicine Products: